Keimyung Medical Journal (KMJ) reviews all manuscripts received. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. If the manuscript meets these two criteria, it is checked for plagiarism or duplicate publication with Similarity Check. After confirmation that no ethical violations have been detected, it is peerreviewed by at least three anonymous reviewers selected by the editor and associate editors. Letters to the editor are reviewed and published on the decision of the editor. The authors’ names and affiliations are removed during the double-blind peer review. The acceptance criteria for all papers are based on the quality and originality of the research as well as their scientific significance. Acceptance of a manuscript is based on the critiques and recommendations of the reviewers. An initial decision will normally be made within three weeks of receipt of a manuscript, and the reviewers’ comments are sent to the corresponding author by e-mail. If choosing to proceed, the corresponding author must indicate all revisions that have been made in response to the reviewers’ comments item by item. Failure to resubmit the revised manuscript within four weeks of the editorial decision is regarded as a withdrawal. If a revision extension period is required, the author should contact the editorial office.

The corresponding author is notified as soon as possible of the editor’s decision to accept, request revision of a manuscript or reject. Once the final revised manuscript satisfactorily conforms to the KMJ format and criteria, it will be scheduled for publication in the next available issue. Rejected papers will no longer be considered for further peer reviews.